EchoVC Partners

EchoVC Partners is a Lagos-based venture firm with a sharp thesis around backing underrepresented founders in invisible markets, deploying $1M-$5M cheques at Seed, Series A, and Series B across AI/ML in healthcare, diagnostics, and digital health. The firm has built a recognisable healthcare portfolio including KangarooHealth, signalling a pattern of preferring sustainable, mission-aligned health and AI plays that combine commercial discipline with development impact. For founders, EchoVC is best understood as a category-defining anchor for African and diaspora founders building defensible health-tech and AI businesses. The right founder profile is an African or African-diaspora operator building digital health, AI clinical tools, or diagnostics with paid customers, a clear scalability path across multiple African markets or into US underserved segments, and ambitions to attract international Series B follow-on. Founders running pure consumer wellness, capital-intensive hospital networks, or US-only plays without underrepresented-market alignment are a poor fit. Entry path is via Eghosa Omoigui directly, an EchoVC portfolio CEO, or warm introductions from co-investing African and US-based funds. In the pitch, lead with mission and commercial alignment, technical defensibility for AI claims, multi-market unit economics, and a credible Series B narrative that names likely international leads. Caveats: EchoVC runs a concentrated, conviction-driven portfolio with high reserves for winners but selective bandwidth for marginal portfolio support, so founders should clarify expectations early. The firm’s AI focus is real and EchoVC is one of the more technically sophisticated African investors, so AI claims will get probed seriously. Confirm reserves and follow-on policy explicitly, and treat EchoVC as a strategic conviction lead rather than a passive co-investor.